Sophia Y Wang1, Chris A Andrews2, Thomas W Gardner3, Michael Wood4, Kanakadurga Singer4, Joshua D Stein5. 1. Department of Ophthalmology and Visual Sciences, University of Michigan Medical School, Ann Arbor. 2. Department of Ophthalmology and Visual Sciences, University of Michigan Medical School, Ann Arbor2Center for Eye Policy and Innovation, University of Michigan, Ann Arbor. 3. Department of Ophthalmology and Visual Sciences, University of Michigan Medical School, Ann Arbor3Michigan Diabetes Research Center, University of Michigan, Ann Arbor. 4. Division of Endocrinology, Department of Pediatrics and Communicable Diseases, University of Michigan, Ann Arbor. 5. Department of Ophthalmology and Visual Sciences, University of Michigan Medical School, Ann Arbor2Center for Eye Policy and Innovation, University of Michigan, Ann Arbor5Department of Health Management and Policy, University of Michigan School of Public Health, Ann Arbor.
Abstract
Importance: Ophthalmic screening to check for diabetic retinopathy (DR) is important to prevent vision loss in persons with diabetes. The American Academy of Ophthalmology recommends that ophthalmic screening for DR occur beginning at 5 years after initial diabetes diagnosis for youths with type 1 diabetes; the American Diabetes Association recommends screening of youths with type 2 diabetes at the time of initial diagnosis. To our knowledge, it is unknown to what extent youths with diabetes obtain eye examinations in accordance with these guidelines. Objective: To assess the rate of obtaining ophthalmic examinations and factors associated with receipt of eye examinations for youths with diabetes. Design, Setting, and Participants: This retrospective, longitudinal cohort study examined youths 21 years or younger with newly diagnosed diabetes enrolled in a US managed care network from January 1, 2001, through December 31, 2014. Main Outcomes and Measures: Kaplan-Meier survival curves estimated the time from initial diabetes diagnosis to first eye examination by an ophthalmologist or optometrist. Multivariable Cox proportional hazards regression models identified factors associated with receiving an ophthalmic examination after initial diabetes diagnosis. Results: Among 5453 youths with type 1 diabetes (median age at initial diagnosis, 11 years; interquartile range, 8-15 years; 2972 male [54.5%]; 4505 white [82.6%]) and 7233 youths with type 2 diabetes (median age at initial diagnosis, 19 years; interquartile range, 16-22 years; 1196 male [16.5%]; 5052 white [69.9%]), 64.9% of patients with type 1 diabetes and 42.2% of patients with type 2 diabetes had undergone an eye examination by 6 years after initial diabetes diagnosis. Black youths (1367 [10.8%] of the sample) had an 11% and Latino youths (1450 [11.4%] of the sample) had an 18% decreased hazard of undergoing an eye examination by 6 years compared with white youths (black youths: adjusted hazard ratio [HR], 0.89; 95% CI, 0.79-0.99; Latino youths: HR, 0.82; 95% CI, 0.73-0.92). As household net worth increased, youths were increasingly more likely to undergo an eye examination by 6 years after initial diabetes diagnosis (net worth of ≥$500 000 vs <$25 000: HR, 1.50; 95% CI, 1.34-1.68). Conclusions and Relevance: Despite possessing health insurance, many youths with diabetes are not receiving eye examinations by 6 years after initial diagnosis to monitor for DR. These data suggest that adherence to clinical practice guidelines is particularly challenging for racial minorities and youths from less affluent families.
Importance: Ophthalmic screening to check for diabetic retinopathy (DR) is important to prevent vision loss in persons with diabetes. The American Academy of Ophthalmology recommends that ophthalmic screening for DR occur beginning at 5 years after initial diabetes diagnosis for youths with type 1 diabetes; the American Diabetes Association recommends screening of youths with type 2 diabetes at the time of initial diagnosis. To our knowledge, it is unknown to what extent youths with diabetes obtain eye examinations in accordance with these guidelines. Objective: To assess the rate of obtaining ophthalmic examinations and factors associated with receipt of eye examinations for youths with diabetes. Design, Setting, and Participants: This retrospective, longitudinal cohort study examined youths 21 years or younger with newly diagnosed diabetes enrolled in a US managed care network from January 1, 2001, through December 31, 2014. Main Outcomes and Measures: Kaplan-Meier survival curves estimated the time from initial diabetes diagnosis to first eye examination by an ophthalmologist or optometrist. Multivariable Cox proportional hazards regression models identified factors associated with receiving an ophthalmic examination after initial diabetes diagnosis. Results: Among 5453 youths with type 1 diabetes (median age at initial diagnosis, 11 years; interquartile range, 8-15 years; 2972 male [54.5%]; 4505 white [82.6%]) and 7233 youths with type 2 diabetes (median age at initial diagnosis, 19 years; interquartile range, 16-22 years; 1196 male [16.5%]; 5052 white [69.9%]), 64.9% of patients with type 1 diabetes and 42.2% of patients with type 2 diabetes had undergone an eye examination by 6 years after initial diabetes diagnosis. Black youths (1367 [10.8%] of the sample) had an 11% and Latino youths (1450 [11.4%] of the sample) had an 18% decreased hazard of undergoing an eye examination by 6 years compared with white youths (black youths: adjusted hazard ratio [HR], 0.89; 95% CI, 0.79-0.99; Latino youths: HR, 0.82; 95% CI, 0.73-0.92). As household net worth increased, youths were increasingly more likely to undergo an eye examination by 6 years after initial diabetes diagnosis (net worth of ≥$500 000 vs <$25 000: HR, 1.50; 95% CI, 1.34-1.68). Conclusions and Relevance: Despite possessing health insurance, many youths with diabetes are not receiving eye examinations by 6 years after initial diagnosis to monitor for DR. These data suggest that adherence to clinical practice guidelines is particularly challenging for racial minorities and youths from less affluent families.
Authors: Jin Xiao Lian; Rita A Gangwani; Sarah M McGhee; Christina K W Chan; Cindy Lo Kuen Lam; David Sai Hung Wong Journal: Br J Ophthalmol Date: 2015-08-13 Impact factor: 4.638
Authors: Thomas J Wubben; Nidhi Talwar; Taylor S Blachley; Thomas W Gardner; Mark W Johnson; Paul P Lee; Joshua D Stein Journal: Ophthalmology Date: 2015-12-31 Impact factor: 12.079
Authors: Eric W Schneider; Prithvi Mruthyunjaya; Nidhi Talwar; Kristen Harris Nwanyanwu; Bin Nan; Joshua D Stein Journal: Invest Ophthalmol Vis Sci Date: 2014-01-29 Impact factor: 4.799
Authors: Terri H Lipman; Lorraine E Levitt Katz; Sarah J Ratcliffe; Kathryn M Murphy; Alexandra Aguilar; Iraj Rezvani; Carol J Howe; Shruti Fadia; Elizabeth Suarez Journal: Diabetes Care Date: 2013-01-22 Impact factor: 19.112
Authors: Jessica Kuo; James C Liu; Ella Gibson; P Kumar Rao; Todd P Margolis; Bradley Wilson; Mae O Gordon; Emily Fondahn; Rithwick Rajagopal Journal: Mo Med Date: 2020 May-Jun
Authors: Rayzel Shulman; Morgan Slater; Shahriar Khan; Carmen Jones; Jennifer D Walker; Kristen Jacklin; Michael E Green; Eliot Frymire; Baiju R Shah Journal: CMAJ Open Date: 2020-01-28
Authors: Mark Porter; Roomasa Channa; Jessica Wagner; Laura Prichett; Tin Yan Alvin Liu; Risa M Wolf Journal: Pediatr Diabetes Date: 2020-05-31 Impact factor: 4.866
Authors: Chelsea Zimmerman; Brittany Bruggeman; Amanda LaPorte; Shalesh Kaushal; Michael Stalvey; Giovanna Beauchamp; Kristin Dayton; Paul Hiers; Stephanie L Filipp; Matthew J Gurka; Janet H Silverstein; Laura M Jacobsen Journal: Diabetes Spectr Date: 2021-01
Authors: Amelia J Lake; Jessica L Browne; Charles Abraham; Dee Tumino; Carolyn Hines; Gwyneth Rees; Jane Speight Journal: BMC Health Serv Res Date: 2018-05-31 Impact factor: 2.655
Authors: Jane L Chiang; David M Maahs; Katharine C Garvey; Korey K Hood; Lori M Laffel; Stuart A Weinzimer; Joseph I Wolfsdorf; Desmond Schatz Journal: Diabetes Care Date: 2018-08-09 Impact factor: 19.112
Authors: Tapan P Patel; Tyson N Kim; Gina Yu; Vaidehi S Dedania; Philip Lieu; Cynthia X Qian; Cagri G Besirli; Hakan Demirci; Todd Margolis; Daniel A Fletcher; Yannis M Paulus Journal: Transl Vis Sci Technol Date: 2019-05-30 Impact factor: 3.283